Purple Biotech Ltd (PPBT)
NASDAQ: PPBT · Real-Time Price · USD
2.480
-0.050 (-1.98%)
At close: Jul 15, 2025, 4:00 PM
2.470
-0.010 (-0.40%)
After-hours: Jul 15, 2025, 7:45 PM EDT
Purple Biotech Employees
Purple Biotech had 9 employees as of December 31, 2024. The number of employees decreased by 11 or -55.00% compared to the previous year.
Employees
9
Change (1Y)
-11
Growth (1Y)
-55.00%
Revenue / Employee
n/a
Profits / Employee
-$436,778
Market Cap
7.10M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 94,300 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
PPBT News
- 22 days ago - Purple Biotech Highlights Significant Advantages of the Novel CAPTN-3 Tri-Specific Antibody Platform at the EACR 2025 Annual Congress - GlobeNewsWire
- 7 weeks ago - Purple Biotech Reports First Quarter 2025 Financial Results - GlobeNewsWire
- 2 months ago - Purple Biotech Appoints Shai Lankry as Chief Financial Officer - GlobeNewsWire
- 2 months ago - Purple Biotech Reports Positive NT219 Data at AACR for Colorectal and Head and Neck Cancers - GlobeNewsWire
- 4 months ago - Purple Biotech Reports Fourth Quarter and Full-Year 2024 Financial Results - GlobeNewsWire
- 5 months ago - Purple Biotech Advances NT219 into Phase 2 Head and Neck Cancer Trial - GlobeNewsWire
- 7 months ago - Purple Biotech Announces Closing of $2.8 Million Registered Direct Offering of American Depositary Shares - GlobeNewsWire
- 8 months ago - Purple Biotech Announces $2.8 Million Registered Direct Offering of American Depositary Shares - GlobeNewsWire